Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer

Teufel, Andreas; Steinmann, Silke; Siebler, Jürgen; Zanke, Christiane; Hohl, Herbert; Adami, Bernd; Schroeder, M.; Klein, O.; Höhler, Thomas; R. Galle, Peter; Heike, Michael; Moehler, Markus

doi:10.1186/1471-2407-4-38

Public

Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer

Published in BMC Cancer • Jul 20, 2004

Authors:

Andreas Teufel

Silke Steinmann

Jürgen Siebler

Abstract

BACKGROUND: Combination therapy of irinotecan, folinic acid (FA) and 5-fluorouracil (5-FU) has been proven to be highly effective for the treatment of metastatic colorectal cancer. However, in light of safety and efficacy concerns, the best combination regimen for first-line therapy still needs to b...

Subject

Folinic acid

Irinotecan

Fluorouracil

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!